Requires Adobe Acrobat Reader

Table 13.6c

Immunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008

Recipients with Heart-Lung Transplants

	No Steroids Used for Maintenance		Steroids Used for Maintenance
	N	%	N	%
Functioning Graft with Immunosuppression Info at Discharge			136	100.0%
Induction Drugs
Atgam/NRATG/NRATS			21	15.4%
OKT3			2	1.5%
Thymoglobulin			9	6.6%
Zenapax			27	19.9%
Simulect			22	16.2%
Campath			17	12.5%
Rituximab			2	1.5%
No Induction Drug Reported			42	30.9%

Source: OPTN/SRTR Data as of May 4, 2009.

Includes patients with a functioning graft at discharge.

Steroids used for induction are not counted.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.

Requires Adobe Acrobat Reader